Trabectedin - CAS# 114899-77-3 Catalog No.:M11024-10 PubMed Central PMCID: PMC5221699
USD1880.00
USD1928.00
Pay in 4 interest-free payments of $470.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Live Spec
Trabectedin - CAS# 114899-77-3 Catalog No.:M11024-10 PubMed Central PMCID: PMC5221699Trabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug
Store: clickpoint.com.au · Domain: clickpoint.com.au
